Clinical Trials

RECRUITING
The Impact of Low Pressure Pneumo in RARP II
The purpose of this study is to evaluate clinical significance of low pressure pneumoperitoneum during robotically assisted radical prostatectomy (RAR...
Conditions:
Prostate Cancer
Locations:
📍 Wyoming, Michigan, United States
NOT_YET_RECRUITING
MAAT For Young Adult Cancer Survivors
The goal of this clinical trial is to pilot-test a modified version of telehealth-delivered Memory and Attention Adaption Training (MAAT) that is tail...
Conditions:
Cancer
Locations:
📍 Indianapolis, Indiana, United States
📍 Pittsburgh, Pennsylvania, United States
📍 Memphis, Tennessee, United States
RECRUITING
INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC
This seamless phase 2/3 randomized controlled study will evaluate the efficacy and safety of the hexavalent OX40 agonist antibody INBRX-106 combined w...
Conditions:
Head and Neck Squamous Cell Carcinoma (HNSCC)
Locations:
📍 Duarte, California, United States
📍 Orange City, Florida, United States
📍 Santa Fe, New Mexico, United States
NOT_YET_RECRUITING
High-Resolution Lower Dose Dedicated Breast Computed Tomography (CT)
This study is being performed to find out if a new kind of breast imaging (called dedicated breast CT or BCT) can help doctors to see the small struct...
Conditions:
Breast Cancer
Locations:
📍 Tucson, Arizona, United States
RECRUITING
Study With Immunotherapy Combinations in Participants With Metastatic Non-Small Cell Lung Cancer
The purpose of this study is to assess the objective response rate (ORR) of immunotherapy-based combination therapy and to assess the safety and toler...
Conditions:
Advanced Non-Small Cell Lung Cancer
Locations:
📍 Birmingham, Alabama, United States
📍 Hollywood, Florida, United States
📍 Port Saint Lucie, Florida, United States
📍 Sarasota, Florida, United States
26 more locations available...
RECRUITING
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
RADICAL PC1 is a prospective cohort study of men with a new diagnosis of prostate cancer. RADICAL PC2 is a randomized, controlled trial of a systemati...
Conditions:
Prostate Cancer Cardiovascular Disease
Locations:
📍 Augusta, Georgia, United States
📍 Kansas City, Kansas, United States
📍 Waratah, New South Wales, Australia
📍 Westmead, New South Wales, Australia
50 more locations available...
RECRUITING
Prospective Evaluation of Targeted Axillary Dissection (TAD)
The purpose of this research is to evaluate how to manage the axillary lymph nodes in patients with breast cancer. The investigators will determine if...
Conditions:
Breast Cancer
Locations:
📍 Miami, Florida, United States
RECRUITING
A Phase 1/2a Study of IMM-1-104 in Participants With Previously Treated, RAS-Mutant, Advanced or Metastatic Solid Tumors
This is an open-label, dose-exploration and expansion study to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary...
Conditions:
Advanced Solid Tumor Pancreatic Adenocarcinoma Malignant Melanoma (Cutaneous) Non-small Cell Lung Cancer (NSCLC)
Locations:
📍 Duarte, California, United States
📍 San Diego, California, United States
📍 Santa Monica, California, United States
📍 Denver, Colorado, United States
11 more locations available...
RECRUITING
A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia
The purpose of this study is to evaluate the efficacy and safety of ibrutinib + venetoclax (I+V) and ibrutinib monotherapy regimens in which dosing of...
Conditions:
Leukemia, Lymphocytic, Chronic, B-Cell Small Lymphocytic Lymphoma
Locations:
📍 Cerritos, California, United States
📍 San Luis Obispo, California, United States
📍 Santa Rosa, California, United States
📍 Whittier, California, United States
56 more locations available...
RECRUITING
Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer
To test the hypothesis that intensive cholesterol lowering (iCL) therapy has anti-tumor immune modulating activity, the investigators will conduct an ...
Conditions:
Prostate Cancer
Locations:
📍 Los Angeles, California, United States
RECRUITING
Role of Novel RADA16 Hydrogel in Endoscopic Skull Base Surgery
The purpose of this study is to specifically evaluate the effectiveness of PuraGel, a RADA16 polypeptide hydrogel, in expediting post-operative healin...
Conditions:
Skull Base Neoplasms Cerebrospinal Fluid Leakage Nasal; Hypertrophy, Mucous Membrane (Septum)
Locations:
📍 Indianapolis, Indiana, United States
RECRUITING
A Study of RP-3500 in Combination With Standard Radiation Therapy in People With Solid Tumor Cancer
The purpose of this study is to test the safety of the study drug, RP-3500 when given in combination with palliative external beam radiotherapy (EBRT)...
Conditions:
Solid Tumor Metastatic Cancer
Locations:
📍 Basking Ridge, New Jersey, United States
📍 Middletown, New Jersey, United States
📍 Montvale, New Jersey, United States
📍 Commack, New York, United States
3 more locations available...
RECRUITING
Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer
Background: Many cancer cells produce substances called antigens that are unique to each cancer. These antigens stimulate the body s immune responses...
Conditions:
Metastatic Solid Cancers Colorectal Cancer Breast Cancer Non-Small Cell Lung Cancer
3 more conditions available...
Locations:
📍 Bethesda, Maryland, United States
RECRUITING
Comparing Retreatment of 177Lu-DOTATATE PRRT Versus Everolimus in Patients With Metastatic Unresectable Midgut Neuroendocrine Tumors, NET RETREAT Trial
This phase II trial compares the effect of retreatment with 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) to the usual approach of treat...
Conditions:
Metastatic Midgut Neuroendocrine Tumor Metastatic Midgut Neuroendocrine Tumor G1 Metastatic Midgut Neuroendocrine Tumor G2 Unresectable Midgut Neuroendocrine Tumor
Locations:
📍 Aurora, Colorado, United States
📍 Jacksonville, Florida, United States
📍 Chicago, Illinois, United States
📍 Rochester, Minnesota, United States
6 more locations available...
RECRUITING
A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN)
This research study is being done to evaluate the safety and effectiveness of sacituzumab govitecan with trastuzumab (Herceptin, Herceptin Hylecta, or...
Conditions:
Her 2 Positive Breast Cancer Breast Cancer Female Breast Cancer Metastatic
Locations:
📍 Boston, Massachusetts, United States
📍 South Weymouth, Massachusetts, United States

Total Trials: 166 - 180 of 6772